These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 29565476)
1. MMP-14 aggravates onset of severe preeclampsia by mediating soluble endoglin release. Zhang XH; Zhang HY; Lu S; Jiang LL; Wu J; Yang YL; Zhang SA Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1209-1215. PubMed ID: 29565476 [TBL] [Abstract][Full Text] [Related]
2. MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin. Kaitu'u-Lino TJ; Palmer KR; Whitehead CL; Williams E; Lappas M; Tong S Am J Pathol; 2012 Mar; 180(3):888-894. PubMed ID: 22296769 [TBL] [Abstract][Full Text] [Related]
3. MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production. Kaitu'u-Lino TJ; Tuohey L; Ye L; Palmer K; Skubisz M; Tong S Placenta; 2013 Feb; 34(2):168-73. PubMed ID: 23261267 [TBL] [Abstract][Full Text] [Related]
4. LIFR increases the release of soluble endoglin via the upregulation of MMP14 expression in preeclampsia. Li H; Yao J; Chang X; Wu J; Duan T; Wang K Reproduction; 2018 Mar; 155(3):297-306. PubMed ID: 29363569 [TBL] [Abstract][Full Text] [Related]
5. Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities. Pérez-Roque L; Núñez-Gómez E; Rodríguez-Barbero A; Bernabéu C; López-Novoa JM; Pericacho M Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375253 [TBL] [Abstract][Full Text] [Related]
6. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta. Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335 [TBL] [Abstract][Full Text] [Related]
7. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia. Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884 [TBL] [Abstract][Full Text] [Related]
8. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells. Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692 [TBL] [Abstract][Full Text] [Related]
9. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia]. Luo X; Liu DD; Qi HB; Yao ZW Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433 [TBL] [Abstract][Full Text] [Related]
10. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083 [TBL] [Abstract][Full Text] [Related]
11. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin. Kaitu'u-Lino TJ; Palmer K; Tuohey L; Ye L; Tong S PLoS One; 2012; 7(6):e39864. PubMed ID: 22768148 [TBL] [Abstract][Full Text] [Related]
12. Soluble endoglin contributes to the pathogenesis of preeclampsia. Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767 [TBL] [Abstract][Full Text] [Related]
13. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14. Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228 [TBL] [Abstract][Full Text] [Related]
14. Oxysterol-induced soluble endoglin release and its involvement in hypertension. Valbuena-Diez AC; Blanco FJ; Oujo B; Langa C; Gonzalez-Nuñez M; Llano E; Pendas AM; Díaz M; Castrillo A; Lopez-Novoa JM; Bernabeu C Circulation; 2012 Nov; 126(22):2612-24. PubMed ID: 23110859 [TBL] [Abstract][Full Text] [Related]
15. Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4. Gallardo-Vara E; Gamella-Pozuelo L; Perez-Roque L; Bartha JL; Garcia-Palmero I; Casal JI; López-Novoa JM; Pericacho M; Bernabeu C Cells; 2020 Apr; 9(4):. PubMed ID: 32316263 [TBL] [Abstract][Full Text] [Related]
16. Exosomes From Women With Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells. Chang X; Yao J; He Q; Liu M; Duan T; Wang K Hypertension; 2018 Dec; 72(6):1381-1390. PubMed ID: 30571229 [TBL] [Abstract][Full Text] [Related]
17. Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes. Leaños-Miranda A; Navarro-Romero CS; Sillas-Pardo LJ; Ramírez-Valenzuela KL; Isordia-Salas I; Jiménez-Trejo LM Hypertension; 2019 Oct; 74(4):991-997. PubMed ID: 31446801 [TBL] [Abstract][Full Text] [Related]
19. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells. Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845 [TBL] [Abstract][Full Text] [Related]
20. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia. Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]